Enhanced External Counterpulsation Improves Long COVID–Associated Symptoms - 16/07/24
Doi : 10.1016/j.amjcard.2024.05.037
Jessie Fox, PharmD a, ⁎ 
, Monica Verduzco-Gutierrez, MD b, Steven Sanchez, DO b, Marielisa Lopez, MD c, Farhan Ali, MD d, Odayme Quesada, MD e, f, Timothy D. Henry, MD e, f, g, Sachin A. Shah, PharmD h
, Monica Verduzco-Gutierrez, MD b, Steven Sanchez, DO b, Marielisa Lopez, MD c, Farhan Ali, MD d, Odayme Quesada, MD e, f, Timothy D. Henry, MD e, f, g, Sachin A. Shah, PharmD h a Director of Medical Affairs, Flow Therapy, Fort Worth, Texas
b Department of Physical Medicine and Rehabilitation, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas
c Department of Physical Medicine and Rehabilitation, UT Southwestern Medical Center, Dallas, Texas
d Heart Center of North Texas, Fort Worth, Texas
e Women's Heart Center at the Christ Hospital, Cincinnati, Ohio
f The Christ Hospital Heart and Vascular Institute, Cincinnati, Ohio
g The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio
h Thomas J Long School of Pharmacy, University of the Pacific, Stockton, California
⁎Corresponding author: Tel: 850-797-9614.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Plan
| Funding: none. |
© 2024
Elsevier Inc. Tous droits réservés.
Vol 224
P. 12-13 - août 2024 Retour au numéro
Article précédent
- Investigating Electrocardiographic Abnormalities in Patients With Coronary Microvascular Dysfunction
- Ilan Merdler, Andrew P. Hill, Sevket Tolga Ozturk, Matteo Cellamare, Cheng Zhang, Kalyan R. Chitturi, Avantika Banerjee, Lior Lupu, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D. Hashim, Brian C. Case
- Comparing Apixaban With Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices
- Cullen Soares, Yash Desai, Erik Sorensen, Lynn Dees, Manjula Ananthram, Albert Hicks
Bienvenue sur EM-consulte, la référence des professionnels de santé.